SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-20-010491
Filing Date
2020-03-12
Accepted
2020-03-12 16:30:50
Documents
114
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K akba-10k_20191231.htm 10-K 5158512
2 EX-4.6 akba-ex46_587.htm EX-4.6 20049
3 EX-10.62 akba-ex1062_588.htm EX-10.62 684621
4 EX-10.63 akba-ex1063_589.htm EX-10.63 204188
5 EX-21.1 akba-ex211_809.htm EX-21.1 22645
6 EX-23.1 akba-ex231_654.htm EX-23.1 14200
7 EX-31.1 akba-ex311_17.htm EX-31.1 17599
8 EX-31.2 akba-ex312_8.htm EX-31.2 17482
9 EX-32.1 akba-ex321_16.htm EX-32.1 12029
10 GRAPHIC girameuzegvg000001.jpg GRAPHIC 48370
  Complete submission text file 0001564590-20-010491.txt   21301021

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT akba-20191231.xml EX-101.INS 4937602
12 XBRL TAXONOMY EXTENSION SCHEMA akba-20191231.xsd EX-101.SCH 125454
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE akba-20191231_cal.xml EX-101.CAL 130700
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akba-20191231_def.xml EX-101.DEF 532015
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE akba-20191231_lab.xml EX-101.LAB 950089
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akba-20191231_pre.xml EX-101.PRE 804406
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36352 | Film No.: 20709214
SIC: 2834 Pharmaceutical Preparations